JNJ vs UNH
Johnson & Johnson vs UnitedHealth Group Incorporated · Updated Jun 29, 2026
JNJ — 13 winsUNH — 10 wins
Price Performance
JNJ +68.36%UNH +34.00%
Performance
| JNJ | UNH | |
|---|---|---|
| 1 Month | +10.23% | +10.72% |
| 3 Months | +6.56% | +58.62% |
| 6 Months | +23.89% | +30.76% |
| YTD | +23.19% | +28.80% |
| 1 Year | +67.42% | +39.12% |
| 3 Year | +46.52% | -10.84% |
| 5 Year | +71.80% | +35.81% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +24.0% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| UNH | +24.3% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
Valuation
| JNJ | UNH | |
|---|---|---|
| P/E Ratio | 29.47 | 32.11 |
| Forward P/E | 11.17 | 9.99 |
| PEG Ratio | 2.75 | 2.08 |
| P/S Ratio | 5.78 | 0.82 |
| P/B Ratio | 6.86 | 3.55 |
| EV/EBITDA | 19.30 | 19.08 |
Financials
| JNJ | UNH | |
|---|---|---|
| EPS (TTM) | $8.65 | $13.24 |
| Gross Margin | +71.49% | +22.74% |
| Operating Margin | +26.58% | +8.05% |
| Net Margin | +21.76% | +5.62% |
| ROE | +25.92% | +11.59% |
| ROA | +10.47% | +3.85% |
| Debt/Equity | 0.22 | 0.75 |
Growth
| JNJ | UNH | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +1.96% |
| Revenue Growth QoQ | -2.04% | -1.32% |
| EPS Growth YoY | -52.86% | +0.73% |
| EPS Growth QoQ | +1.90% | +62627.30% |
Technical
| JNJ | UNH | |
|---|---|---|
| RSI (14) | 71.11 | 65.97 |
| % From 20-Day SMA | +8.79% | +5.82% |
| % From 50-Day SMA | +10.53% | +11.03% |
| % From 200-Day SMA | +17.30% | +26.47% |
| % From 52-Week High | -0.06% | -0.64% |
| % From 52-Week Low | +68.83% | +81.24% |
Analyst Ratings
JNJ
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$253.42
-0.60% upside
UNH
Buy(37 analysts)
Strong SellHoldStrong Buy
Price Target
$425.81
+0.15% upside
Overview
| JNJ | UNH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $556.76B | $369.32B |
| Shares Outstanding | 2.41B | 908.1M |
| Avg Volume (10D) | 10.44M | 7.28M |
| Dividend Yield | 2.27% | 2.20% |
Frequently Asked Questions
Is JNJ or UNH a better buy right now?
Based on 23 comparable metrics, JNJ leads in 13 categories while UNH leads in 10. JNJ has a consensus analyst rating with 24 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or UNH?
Over the past year, JNJ returned +67.42% compared to UNH's +39.12%. In the short term (1 month), JNJ returned +10.23% vs UNH's +10.72%.
Is JNJ or UNH more expensive?
JNJ trades at a P/E of 29.47 compared to UNH's 32.11. On a price-to-sales basis, JNJ trades at 5.78x vs UNH's 0.82x. Forward P/E: JNJ at 11.17 vs UNH at 9.99.
Which stock has higher growth, JNJ or UNH?
JNJ's revenue grew +9.91% year-over-year compared to UNH's +1.96%. EPS growth: JNJ at -52.86% vs UNH at +0.73%.
Do JNJ and UNH pay dividends?
JNJ pays a dividend with a yield of 2.27%. UNH pays a dividend with a yield of 2.20%.
Which stock do analysts prefer, JNJ or UNH?
JNJ has 24 analysts with a target price of $253.42 (-0.60% upside). UNH has 37 analysts with a target of $425.81 (+0.15% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.